By Associate Professor Meg Jardine

Journal articles

Jun M; Harris K; Heerspink HJL; Badve SV; Jardine MJ; Harrap S; Hamet P; Marre M; Poulter N; Kotwal S; Gallagher M; Perkovic V; Chalmers J; Woodward M, 2021, 'Variability in estimated glomerular filtration rate and the risk of major clinical outcomes in diabetes: Post hoc analysis from the ADVANCE trial', Diabetes, Obesity and Metabolism, 23, pp. 1420 - 1425, http://dx.doi.org/10.1111/dom.14351

Ye N; Jardine MJ; Oshima M; Hockham C; Heerspink HJL; Agarwal R; Bakris G; Schutte AE; Arnott C; Chang TI; Górriz JL; Cannon CP; Charytan DM; De Zeeuw D; Levin A; Mahaffey KW; Neal B; Pollock C; Wheeler DC; Luca Di Tanna G; Cheng H; Perkovic V; Neuen BL; Di Tanna GL, 2021, 'Blood Pressure Effects of Canagliflozin and Clinical Outcomes in Type 2 Diabetes and Chronic Kidney Disease: Insights From the CREDENCE Trial', Circulation, 143, pp. 1735 - 1749, http://dx.doi.org/10.1161/CIRCULATIONAHA.120.048740

Zhou Z; Jardine MJ; Li Q; Neuen BL; Cannon CP; De Zeeuw D; Edwards R; Levin A; Mahaffey KW; Perkovic V; Neal B; Lindley RI; Guerrero RAA; Aizenberg D; Albisu JP; Alvarisqueta A; Bartolacci I; Berli MA; Bordonava A; Calella P; Cantero MC; Cartasegna LR; Cercos E; Coloma GC; Colombo H; Commendatore V; Cuadrado J; Cuneo CA; Cusumano AM; Douthat WG; Dran RD; Farias E; Fernandez MF; Finkelstein H; Fragale G; Fretes JO; Garcia NH; Gastaldi A; Gelersztein E; Glenny JA; Gonzalez JP; Del Carmen Gonzalez Colaso P; Goycoa C; Greloni GC; Guinsburg A; Hermida S; Juncos LI; Klyver MI; Kraft F; Krynski F; Lanchiotti PV; De La Fuente RAL; Marchetta N; Mele P; Nicolai S; Novoa PA; Orio SI; Otreras F; Oviedo A; Raffaele P; Resk JH; Rista L; Papini NR; Sala J; Santos JC; Schiavi LB; Sessa H; Casabella TS; Ulla MR; Valdez M; Vallejos A; Villarino A; Visco VE; Wassermann A; Zaidman CJ; Cheung NW; Droste C; Fraser I; Johnson D; Mah PM; Nicholls K; Packham D; Proietto J; Roberts A; Roger S; Tsang V; Raduan RA; Da Costa FAA; Amodeo C; Turatti LAA; Bregman R; Sanches FCC; Canani LH; Chacra AR; Borges JLC; Vêncio SAC; Da Silva Franco RJ; D'Avila D; De Souza Portes E; De Souza P; Phillips A, 2021, 'Effect of SGLT2 inhibitors on stroke and atrial fibrillation in diabetic kidney disease: Results from the CREDENCE trial and meta-analysis', Stroke, 52, pp. 1545 - 1556, http://dx.doi.org/10.1161/STROKEAHA.120.031623

Yu J; Arnott C; Neuen BL; Heersprink HL; Mahaffey KW; Cannon CP; Khan SS; Baldridge AS; Shah SJ; Huang Y; Li C; Figtree GA; Perkovic V; Jardine MJ; Neal B; Huffman MD, 2021, 'Cardiovascular and renal outcomes with canagliflozin according to baseline diuretic use: a post hoc analysis from the CANVAS Program', ESC Heart Failure, 8, pp. 1482 - 1493, http://dx.doi.org/10.1002/ehf2.13236

Clase CM; Fu EL; Jardine M; Mann JFE; Carrero JJ, 2021, 'In response', Annals of Internal Medicine, 174, pp. 580, http://dx.doi.org/10.7326/L21-0091

Oshima M; Jardine MJ; Agarwal R; Bakris G; Cannon CP; Charytan DM; de Zeeuw D; Edwards R; Greene T; Levin A; Lim SK; Mahaffey KW; Neal B; Pollock C; Rosenthal N; Wheeler DC; Zhang H; Zinman B; Perkovic V; Heerspink HJL, 2021, 'Insights from CREDENCE trial indicate an acute drop in estimated glomerular filtration rate during treatment with canagliflozin with implications for clinical practice', Kidney International, 99, pp. 999 - 1009, http://dx.doi.org/10.1016/j.kint.2020.10.042

Nataatmadja M; Krishnasamy R; Zuo L; Hong D; Smyth B; Jun M; de Zoysa JR; Howard K; Wang J; Lu C; Liu Z; Chan CT; Cass A; Perkovic V; Jardine M; Gray NA, 2021, 'Quality of Life in Caregivers of Patients Randomized to Standard- Versus Extended-Hours Hemodialysis', Kidney International Reports, 6, pp. 1058 - 1065, http://dx.doi.org/10.1016/j.ekir.2021.01.020

Ng JKC; Smyth B; Marshall MR; Kang A; Pinter J; Bassi A; Krishnasamy R; Rossignol P; Rocco MV; Li Z; Jha V; Hawley CM; Kerr PG; Di Tanna GL; Woodward M; Jardine AM, 2021, 'Relationship between measured and prescribed dialysate sodium in haemodialysis: A systematic review and meta-Analysis', Nephrology Dialysis Transplantation, 36, pp. 695 - 703, http://dx.doi.org/10.1093/ndt/gfaa287

Sarraju A; Li JW; Cannon CP; Chang TI; Agarwal R; Bakris G; Charytan DM; de Zeeuw D; Greene T; Heerspink HJL; Levin A; Neal B; Pollock C; Wheeler DC; Yavin Y; Zhang H; Zinman B; Perkovic V; Jardine M; Mahaffey KW, 2021, 'Effects of canagliflozin on cardiovascular, renal, and safety outcomes in participants with type 2 diabetes and chronic kidney disease according to history of heart failure: Results from the CREDENCE trial', American Heart Journal, 233, pp. 141 - 148, http://dx.doi.org/10.1016/j.ahj.2020.12.008

Barisoni L; Barratt J; Campbell K; Eva L; Gillespie BS; Gipson D; Huber T; Jardine M; Kamil E; Kretzler M; Lee L; Levtchenk E; Mehr AP; Nachman PH; Oh J; Saleem M; Shankland SJ; Smith K; Smokler I; Smoyer W; Tarnoff J; Thompson A; Trachtman H; Udani S; Vivarelli M; Walker P; West M; Rovin BH, 2021, 'Innovating and invigorating the clinical trial infrastructure for glomerular diseases', Kidney International, 99, pp. 519 - 523, http://dx.doi.org/10.1016/j.kint.2020.09.038

O'Hara DV; Parkhill TR; Badve SV; Jun M; Jardine MJ; Perkovic V, 2021, 'The effects of dipeptidyl peptidase-4 inhibitors on kidney outcomes', Diabetes, Obesity and Metabolism, 23, pp. 763 - 773, http://dx.doi.org/10.1111/dom.14281

Evans RDR; Smyth B; Levin A; Jha V; Wheeler DC; Jardine M; Perkovic V; Damster S; Malik C; de Zeeuw D; Hiemstra T, 2021, 'The International Society of Nephrology Advancing Clinical Trials (ISN-ACT) Network: current activities and future goals', Kidney International, 99, pp. 551 - 554, http://dx.doi.org/10.1016/j.kint.2020.10.048

Yu J; Zhou Z; Mahaffey KW; Matthews DR; Neuen BL; Heerspink HJL; Jardine MJ; Li JW; Perkovic V; Neal B; Arnott C, 2021, 'An exploration of the heterogeneity in effects of SGLT2 inhibition on cardiovascular and all-cause mortality in the EMPA-REG OUTCOME, CANVAS Program, DECLARE-TIMI 58, and CREDENCE trials', International Journal of Cardiology, 324, pp. 165 - 172, http://dx.doi.org/10.1016/j.ijcard.2020.09.050

Oshima M; Hara A; Toyama T; Jun M; Pollock C; Jardine M; Harrap S; Poulter N; Cooper ME; Woodward M; Chalmers J; Perkovic V; Wong MG; Wada T, 2021, 'Comparison of Circulating Biomarkers in Predicting Diabetic Kidney Disease Progression With Autoantibodies to Erythropoietin Receptor', Kidney International Reports, 6, pp. 284 - 295, http://dx.doi.org/10.1016/j.ekir.2020.10.039

Kang A; Jardine MJ, 2021, 'SGLT2 inhibitors may offer benefit beyond diabetes', Nature Reviews Nephrology, 17, pp. 83 - 84, http://dx.doi.org/10.1038/s41581-020-00391-2

Neuen BL; Arnott C; Perkovic V; Figtree G; de Zeeuw D; Fulcher G; Jun M; Jardine MJ; Zoungas S; Pollock C; Mahaffey KW; Neal B; Heerspink HJL, 2021, 'Sodium-glucose co-transporter-2 inhibitors with and without metformin: A meta-analysis of cardiovascular, kidney and mortality outcomes', Diabetes, Obesity and Metabolism, 23, pp. 382 - 390, http://dx.doi.org/10.1111/dom.14226

Athavale A; Morris J; Jardine M; Gallagher M; Sen S; Ritchie A; Wang AY, 2021, 'Acute interstitial nephritis and nephrogenic diabetes insipidus following treatment with sulfamethoxazole-trimethoprim and temozolomide', Nephrology, 26, pp. 12 - 14, http://dx.doi.org/10.1111/nep.13783

Jardine M; Zhou Z; Lambers Heerspink HJ; Hockham C; Li Q; Agarwal R; Bakris GL; Cannon CP; Charytan DM; Greene T; Levin A; Li JW; Neuen BL; Neal B; Oh R; Oshima M; Pollock C; Wheeler DC; de Zeeuw D; Zhang H; Zinman B; Mahaffey KW; Perkovic V, 2021, 'Kidney, cardiovascular, and safety outcomes of canagliflozin according to baseline albuminuria a credence secondary analysis', Clinical Journal of the American Society of Nephrology, 16, pp. 384 - 395, http://dx.doi.org/10.2215/CJN.15260920

Neuen BL; Ohkuma T; Neal B; Matthews DR; de Zeeuw D; Mahaffey KW; Fulcher G; Blais J; Li Q; Jardine MJ; Perkovic V; Wheeler DC, 2021, 'Relative and Absolute Risk Reductions in Cardiovascular and Kidney Outcomes With Canagliflozin Across KDIGO Risk Categories: Findings From the CANVAS Program', American Journal of Kidney Diseases, 77, pp. 23 - 34.e1, http://dx.doi.org/10.1053/j.ajkd.2020.06.018

Li C; Zhou Z; Neuen BL; Yu J; Huang Y; Young T; Li J; Li L; Perkovic V; Jardine MJ; Keay L; Markoulli M; Rosenthal N; Capuano G; Yavin Y; Neal B; Arnott C, 2021, 'Sodium-glucose co-transporter-2 inhibition and ocular outcomes in patients with type 2 diabetes: A systematic review and meta-analysis', Diabetes, Obesity and Metabolism, 23, pp. 252 - 257, http://dx.doi.org/10.1111/dom.14197

Neuen BL; Jardine MJ; Perkovic V, 2021, 'Sodium-glucose cotransporter 2 inhibition: Which patient with chronic kidney disease should be treated in the future?', Nephrology Dialysis Transplantation, 35, pp. I48 - I55, http://dx.doi.org/10.1093/NDT/GFZ252

Yu J; Arnott C; Neuen BL; Heersprink HL; Mahaffey KW; Cannon CP; Khan SS; Baldridge AS; Shah SJ; Huang Y; Li C; Figtree GA; Perkovic V; Jardine MJ; Neal B; Huffman MD, 2021, 'Corrigendum', ESC Heart Failure, 8, pp. 3447 - 3447, http://dx.doi.org/10.1002/ehf2.13408

Bakris G; Oshima M; Mahaffey KW; Agarwal R; Cannon CP; Capuano G; Charytan DM; de Zeeuw D; Edwards R; Greene T; Heerspink HJL; Levin A; Neal B; Oh R; Pollock C; Rosenthal N; Wheeler DC; Zhang H; Zinman B; Jardine MJ; Perkovic V, 2020, 'Effects of canagliflozin in patients with baseline eGFR <30 ml/min per 1.73 m²: Subgroup analysis of the randomized CREDENCE trial', Clinical Journal of the American Society of Nephrology, 15, pp. 1705 - 1714, http://dx.doi.org/10.2215/CJN.10140620

Oshima M; Neuen BL; Li JW; Perkovic V; Charytan DM; de Zeeuw D; Edwards R; Greene T; Levin A; Mahaffey KW; de Nicola L; Pollock C; Rosenthal N; Wheeler DC; Jardine MJ; Heerspink HJL, 2020, 'Early change in albuminuria with canagliflozin predicts kidney and cardiovascular outcomes: A post hoc analysis from the Credence trial', Journal of the American Society of Nephrology, 31, pp. 2925 - 2936, http://dx.doi.org/10.1681/ASN.2020050723

Sukkar L; Young T; Jardine MJ, 2020, 'How Do the Recent Major Randomized Controlled Trials Inform Best Use of the Novel Glucose-Lowering Agents?', Kidney and Blood Pressure Research, 45, pp. 823 - 836, http://dx.doi.org/10.1159/000511214

Zhang H; Rogers K; Sukkar L; Jun M; Kang A; Young T; Campain A; Cass A; Chow CK; Comino E; Foote C; Gallagher M; Knight J; Liu B; Lung T; McNamara M; Peiris D; Pollock C; Sullivan D; Wong G; Zoungas S; Jardine M; Hockham C, 2020, 'Prevalence, incidence and risk factors of diabetes in Australian adults aged ≥45 years: A cohort study using linked routinely-collected data', Journal of Clinical and Translational Endocrinology, 22, pp. 100240, http://dx.doi.org/10.1016/j.jcte.2020.100240

Toussaint ND; Pedagogos E; Lioufas NM; Elder GJ; Pascoe EM; Badve SV; Valks A; Block GA; Boudville N; Cameron JD; Campbell KL; Chen SSM; Faull RJ; Holt SG; Jackson D; Jardine MJ; Johnson DW; Kerr PG; Lau KK; Hooi LS; Narayan O; Perkovic V; Polkinghorne KR; Pollock CA; Reidlinger D; Robison L; Smith ER; Walker RJ; Wang AYM; Hawley CM; Wyndham R; Vilayur E; Cooper B; Wong MG; Tan KS; van Eps C; Cho Y; Barbara J; Paizis K; McMahon LP; Nelson C; Gafor AHA; Meng OL; Mushahar L; Maher E, 2020, 'A randomized trial on the effect of phosphate reduction on vascular end points in CKD (improve-CKD)', Journal of the American Society of Nephrology, 31, pp. 2653 - 2666, http://dx.doi.org/10.1681/ASN.2020040411

Oshima M; Neuen BL; Jardine MJ; Bakris G; Edwards R; Levin A; Mahaffey KW; Neal B; Pollock C; Rosenthal N; Wada T; Wheeler DC; Perkovic V; Heerspink HJL, 2020, 'Effects of canagliflozin on anaemia in patients with type 2 diabetes and chronic kidney disease: a post-hoc analysis from the CREDENCE trial', The Lancet Diabetes and Endocrinology, 8, pp. 903 - 914, http://dx.doi.org/10.1016/s2213-8587(20)30300-4

Smyth B; Chan CT; Grieve SM; Puranik R; Zuo L; Hong D; Gray NA; de Zoysa JR; Scaria A; Gallagher M; Perkovic V; Jardine M, 2020, 'Response to: Loutradis et al. Longer Dialysis Sessions Improve Cardiac Systolic Function by Reducing Myocardial Stunning', Journal of Cardiac Failure, 26, pp. 1028 - 1029, http://dx.doi.org/10.1016/j.cardfail.2020.09.001

Arnott C; Neuen BL; Heerspink HJL; Figtree GA; Kosiborod M; Lam CS; Cannon CP; Rosenthal N; Shaw W; Mahaffey KW; Jardine MJ; Perkovic V; Neal B, 2020, 'The effects of combination canagliflozin and glucagon-like peptide-1 receptor agonist therapy on intermediate markers of cardiovascular risk in the CANVAS program', International Journal of Cardiology, 318, pp. 126 - 129, http://dx.doi.org/10.1016/j.ijcard.2020.06.011

Xie Y; Baker J; Young T; Jun M; Sukkar L; Campain A; Kang A; Cass A; Hu J; Peiris D; Pollock C; Wong G; Zoungas S; Rogers K; Jardine M; Hockham C, 2020, 'Therapy escalation following an elevated hba1c in adults aged 45 years and older living with diabetes in Australia: A real-world observational analysis', Diabetes Care, 43, pp. e185 - e187, http://dx.doi.org/10.2337/dc20-0269

Clase CM; Fu EL; Ashur A; Beale RCL; Clase IA; Dolovich MB; Jardine MJ; Joseph M; Kansiime G; Mann JFE; Pecoits-Filho R; Winkelmayer WC; Carrero JJ, 2020, 'Forgotten Technology in the COVID-19 Pandemic: Filtration Properties of Cloth and Cloth Masks—A Narrative Review', Mayo Clinic Proceedings, 95, pp. 2204 - 2224, http://dx.doi.org/10.1016/j.mayocp.2020.07.020

O’Lone E; Howell M; Viecelli AK; Craig JC; Tong A; Sautenet B; Herrington WG; Herzog CA; Jafar TH; Jardine M; Krane V; Levin A; Malyszko J; Rocco MV; Strippoli G; Tonelli M; Wang AYM; Wanner C; Zannad F; Winkelmayer WC; Wheeler DC, 2020, 'Identifying critically important cardiovascular outcomes for trials in hemodialysis: An international survey with patients, caregivers and health professionals', Nephrology Dialysis Transplantation, 35, pp. 1761 - 1769, http://dx.doi.org/10.1093/ndt/gfaa008

Levin A; Agarwal R; Herrington WG; Heerspink HL; Mann JFE; Shahinfar S; Tuttle KR; Donner JA; Jha V; Nangaku M; de Zeeuw D; Jardine MJ; Mahaffey KW; Thompson AM; Beaucage M; Chong K; Roberts GV; Sunwold D; Vorster H; Warren M; Damster S; Malik C; Perkovic V; Anand S; Argent N; Babak E; Banerjee D; Barratt J; Bello AK; Bernardo AA; Blais J; Canovatchel W; Caskey FJ; Coresh J; de Boer IH; Eckardt KU; Evans RD; Feldman HI; Fogo AB; Gudmundsdottir H; Hamano T; Harris DCH; Hauske SJ; Haynes R; Herzog CA; Hiemstra T; Idorn T; Inker L; Ishida JH; Johnson DW; Jones-Burton C; Joseph A; Koitka-Weber A; Kretzler M; Lawatscheck R; Liew A; Moist L; Naicker S; Nakashima R; Patel U; Filho RP; Rose JB; Rosenberg NL; Sinsakul M; Smoyer WE; Sola L; Sood AR; Stengel B; Taal MW; Tanaka M; Tonelli M; Tong A; Toto R; Trask M; Ulasi II; Wanner C; Wheeler DC; Wolthers BO; Wright HM; Yamada Y; Zakharova E, 2020, 'International consensus definitions of clinical trial outcomes for kidney failure: 2020', Kidney International, 98, pp. 849 - 859, http://dx.doi.org/10.1016/j.kint.2020.07.013

O’Hara DV; Neuen BL; Jardine MJ, 2020, 'Kidney and cardiovascular protection with SGLT2 inhibitors: lessons from cardiovascular outcome trials and CREDENCE', Journal of Nephrology, 33, pp. 977 - 983, http://dx.doi.org/10.1007/s40620-020-00809-x

Smyth B; Zuo L; Gray NA; Chan CT; de Zoysa JR; Hong D; Rogers K; Wang J; Cass A; Gallagher M; Perkovic V; Jardine M, 2020, 'No evidence of a legacy effect on survival following randomization to extended hours dialysis in the ACTIVE Dialysis trial', Nephrology, 25, pp. 792 - 800, http://dx.doi.org/10.1111/nep.13737

Zhu B; Jun M; Jardine MJ; Wang YJ; Perkovic V, 2020, 'Haemodialysis duration, frequency and intensity for end-stage kidney disease', Cochrane Database of Systematic Reviews, 2020, http://dx.doi.org/10.1002/14651858.CD010064.pub2

Clase CM; Fu EL; Joseph M; Beale RCL; Dolovich MB; Jardine M; Mann JFE; Pecoits-Filho R; Winkelmayer WC; Carrero JJ, 2020, 'Cloth masks may prevent transmission of COVID-19: An evidence-based, risk-based approach', Annals of Internal Medicine, 173, pp. 489 - 492, http://dx.doi.org/10.7326/M20-2567

Shaman AM; Smyth B; Arnott C; Palmer SC; Mihailidou AS; Jardine MJ; Gallagher MP; Perkovic V; Jun M, 2020, 'Comparative efficacy and safety of bp-lowering pharmacotherapy in patients undergoing maintenance dialysis: A network meta-analysis of randomized, controlled trials', Clinical Journal of the American Society of Nephrology, 15, pp. 1129 - 1138, http://dx.doi.org/10.2215/CJN.12201019

Krishnasamy R; Hawley CM; Jardine MJ; Roberts MA; Cho Y; Wong M; Heath A; Nelson CL; Sen S; Mount PF; Pascoe EM; Vergara LA; Paul-Brent PA; Toussaint ND; Johnson DW; Hutchison CA, 2020, 'A trial evaluating mid cut-off value membrane clearance of albumin and light chains in hemodialysis patients: A safety device study', Blood Purification, 49, pp. 468 - 478, http://dx.doi.org/10.1159/000505567

LI J; JARDINE MJ; NEAL B; HEERSPINK HL; CANNON C; AGARWAL R; BAKRIS G; CHARYTAN DM; ZEEUW DD; EDWARDS R; GREENE TOM; LEVIN A; POLLOCK CA; ROSENTHAL N; WHEELER DC; ZHANG H; ZINMAN B; PERKOVIC V; MAHAFFEY KW; ARNOTT C, 2020, '27-OR: Effect of Canagliflozin on Total Hospitalization for Heart Failure Events in Patients with Type 2 Diabetes and Chronic Kidney Disease', Diabetes, 69, http://dx.doi.org/10.2337/db20-27-or

Kang A; Neuen B; Heerspink HL; Di Tanna GL; Neal B; Zhang H; Hockham C; Agarwal R; Bakris G; Charytan DM; De Zeeuw D; Greene T; Levin A; Pollock C; Wheeler D; Zinman B; Mahaffey KW; Perkovic V; Jardine M; Lambers Heerspink H, 2020, 'P1013CANAGLIFLOZIN AND RISK OF GENITAL INFECTIONS AND URINARY TRACT INFECTIONS IN PEOPLE WITH DIABETES MELLITUS AND KIDNEY DISEASE- A POST-HOC ANALYSIS OF THE CREDENCE TRIAL', Nephrology Dialysis Transplantation, 35, pp. gfaa142.p1013, http://dx.doi.org/10.1093/ndt/gfaa142.p1013

Kang A; Smyth B; Neuen B; Lambers Heerspink H; Di Tanna GL; Neal B; Zhang H; Hockham C; Agarwal R; Bakris G; Charytan DM; De Zeeuw D; Greene T; Levin A; Pollock C; Wheeler D; Zinman B; Mahaffey KW; Perkovic V; Jardine M, 2020, 'P1019CANAGLIFLOZIN AND RISK OF SKIN AND SOFT TISSUE INFECTIONS IN PEOPLE WITH DIABETES MELLITUS AND KIDNEY DISEASE - A POST-HOC ANALYSIS OF THE CREDENCE TRIAL', Nephrology Dialysis Transplantation, 35, http://dx.doi.org/10.1093/ndt/gfaa142.p1019

Young T; Li J-W; Kang A; Heerspink H; Hockham C; Arnott C; Neuen B; Zoungas S; Mahaffey KW; Perkovic V; De Zeeuw D; Fulcher G; Neal B; Jardine M, 2020, 'P1028EFFECTS OF CANAGLIFLOZIN ON MAJOR ADVERSE CARDIOVASCULAR OUTCOMES IN PATIENTS WITH DIFFERENT BASELINE LEVELS OF TYPE 2 DIABETES MELLITUS DISEASE SEVERITY: RESULTS FROM THE CANVAS PROGRAM', Nephrology Dialysis Transplantation, 35, pp. gfaa142.p1028, http://dx.doi.org/10.1093/ndt/gfaa142.p1028

Smyth B; Chan CT; Grieve SM; Puranik R; Zuo L; Hong D; Gray NA; De Zoysa JR; Scaria A; Gallagher M; Perkovic V; Jardine M, 2020, 'Predictors of Change in Left-Ventricular Structure and Function in a Trial of Extended Hours Hemodialysis', Journal of Cardiac Failure, 26, pp. 482 - 491, http://dx.doi.org/10.1016/j.cardfail.2020.03.010

Arnott C; Huang Y; Neuen BL; Di Tanna GL; Cannon CP; Oh R; Edwards R; Kavalam M; Rosenthal N; Perkovic V; Jardine MJ; Mahaffey K; Neal B, 2020, 'The effect of canagliflozin on amputation risk in the CANVAS program and the CREDENCE trial.', Diabetes Obes Metab, 22, pp. 1753 - 1766, http://dx.doi.org/10.1111/dom.14091

Sriravindrarajah A; Kotwal SS; Sen S; McDonald S; Jardine M; Cass A; Gallagher M, 2020, 'Impact of supplemental private health insurance on dialysis and outcomes', Internal Medicine Journal, 50, pp. 542 - 549, http://dx.doi.org/10.1111/imj.14375

Sukkar L; Kang A; Hockham C; Young T; Jun M; Foote C; Pecoits-Filho R; Neuen B; Rogers K; Pollock C; Cass A; Sullivan D; Wong G; Knight J; Peiris D; Gallagher M; Jardine M, 2020, 'Incidence and associations of chronic kidney disease in community participants with diabetes: A 5-year prospective analysis of the EXTEND45 study', Diabetes Care, 43, pp. 982 - 990, http://dx.doi.org/10.2337/dc19-1803

Jardine MJ; Zhou Z; Mahaffey KW; Oshima M; Agarwal R; Bakris G; Bajaj HS; Bull S; Cannon CP; Charytan DM; De Zeeuw D; Di Tanna GL; Greene T; Heerspink HJL; Levin A; Neal B; Pollock C; Qiu R; Sun T; Wheeler DC; Zhang H; Zinman B; Rosenthal N; Perkovic V, 2020, 'Renal, cardiovascular, and safety outcomes of canagliflozin by baseline kidney function: A secondary analysis of the CREDENCE randomized trial', Journal of the American Society of Nephrology, 31, pp. 1128 - 1139, http://dx.doi.org/10.1681/ASN.2019111168

Foote C; Hockham C; Sukkar L; Campain A; Kang A; Young T; Cass A; Chow CK; Comino E; Gallagher M; Jan S; Knight J; Liu B; McNamara M; Peiris D; Pollock C; Sullivan D; Wong G; Zoungas S; Rogers K; Jun M; Jardine M; Harris M, 2020, 'Examining outcomes in chronic Disease in the 45 and Up Study (the EXTEND45 Study): Protocol for an Australian Linked Cohort Study', JMIR Research Protocols, 9, pp. e15646, http://dx.doi.org/10.2196/15646

Back to profile page